Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Cheryl L, Renz"'
Publikováno v:
Drug Safety. 44:733-742
Antibody-drug conjugates (ADCs) are new treatment options for certain cancers, especially those in advanced states with limited treatment options. Their unique design provides targeted therapy with toxins that otherwise would not be available, but th
Publikováno v:
Value in Health. 22:728-738
Objectives To quantify patient preferences for endometriosis-associated pain treatments and risk tolerance in exchange for pain reduction and to explore whether preferences vary on the basis of patient characteristics. Methods US women with a self-re
Autor:
Fabio A, Lievano, Linda J, Scarazzini, Jerzy E, Tyczynski, Charles M, Schubert, Cheryl L, Renz
Publikováno v:
Drug safety. 44(7)
Antibody-drug conjugates (ADCs) are new treatment options for certain cancers, especially those in advanced states with limited treatment options. Their unique design provides targeted therapy with toxins that otherwise would not be available, but th
Autor:
Christine Poulos, Sanjay K. Agarwal, M. Bhattacharya, Ahmed M. Soliman, Joshua Posner, Cheryl L. Renz
Publikováno v:
Fertility and Sterility. 110:e389
Publikováno v:
Diabetes, Obesity and Metabolism. 8:206-213
Background: Early weight loss is generally considered to predict long-term weight outcome in obese patients, and this is reflected in prescribing guidelines for antiobesity drugs. For example, the current prescribing guidelines for the antiobesity dr
Autor:
Ann Hsu, Cheryl L. Renz, Ping Jiang, Nancy S. Shulman, Joel E. Gallant, Diane V. Havlir, Sheila Boller, Eugene Sun, Dale J. Kempf, Elizabeth Race, Andrew R. Zolopa, Richard A. Rode
Publikováno v:
Antimicrobial Agents and Chemotherapy. 46:3907-3916
Depending on the degree of underlying resistance present, optimization of the pharmacokinetics of protease inhibitors may result in improved virologic suppression. Thirty-seven human immunodeficiency virus (HIV)-infected subjects who had chronic dete
Publikováno v:
Critical Care Medicine. 27:1732-1737
To determine whether pretreatment with intravenous antihistamines attenuates the symptoms of red-man syndrome associated with rapid vancomycin administration.Prospective, randomized, double-blinded, placebo-controlled study of patients undergoing ele
Autor:
John D. Thurn, Cheryl L. Renz, D. Laroche, James P. Lynch, Ronald A. Thisted, Henry A. Finn, Jonathan Moss
Publikováno v:
Anesthesiology. 89:620-625
Background Anaphylaxis, mediated by immunoglobulin E, may be clinically indistinguishable but is mechanistically different than chemically mediated anaphylactoid reactions induced by drugs such as morphine, curare, and vancomycin. A test to distingui
Publikováno v:
Anesthesia & Analgesia. 87:681-685
Rapid infusion of vancomycin causes histamine-mediated side effects, hypotension, and rash, known as red man syndrome. In this prospective, randomized, double-blind, placebo-controlled study, we examined the ability of oral antihistamines to attenuat
Autor:
Jordi Salas-Salvado, W. Philip T. James, Ian D. Caterson, Walmir Coutinho, Nick Finer, Luc F. Van Gaal, Aldo P. Maggioni, Christian Torp-Pedersen, Arya M. Sharma, Gillian M. Shepherd, Richard A. Rode, Cheryl L. Renz, SCOUT Investigators
Publikováno v:
New England Journal of Medicine
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular events and cardiovascular death among subjects at high cardiovascular risk hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3351::52aad22ab3f30198d2837494121301da
http://hdl.handle.net/20.500.11797/PC1752
http://hdl.handle.net/20.500.11797/PC1752